---
figid: PMC12222209__fcell-13-1584630-g001
figtitle: Main mechanism for cancer undergoes MDR
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12222209
filename: fcell-13-1584630-g001.jpg
figlink: /pmc/articles/PMC12222209/figure/F1/
number: F1
caption: The main mechanism for cancer undergoes MDR. The PI3K/Akt signaling pathway
  enhances the drug efflux capacity of ABC transporters by facilitating energy supply
  through aerobic glycolysis. Hypoxia-inducible factor 1-alpha (HIF-1α) activates
  the transcription of various genes, such as vascular endothelial growth factor (VEGF),
  glucose transporters, and glycolytic enzymes, thereby modulating glucose metabolism
  to support the Warburg effect and regulating the expression of ABC transport proteins.
  Additionally, c-Myc influences glucose metabolism and augments the expression and
  activity of ABCG2. These signaling pathways reprogram glucose metabolism and impact
  the expression of ABCs transporter proteins (P-gp, MRP1, ABCG2, etc.), resulting
  in cancer MDR. MDR, multidrug resistance; HIF-1α, hypoxia-inducible factor 1-alpha;
  VEGF, vascular endothelial growth factor; ABCG2, ATP-binding cassette transporter
  G2; P-gp, P-glycoprotein; MRP1, multidrug resistance related protein 1
papertitle: The role and therapeutic potential of glucose metabolism in multidrug
  resistance of cancer
reftext: Qijing Wang, et al. Front Cell Dev Biol. 2025;13(NA).
year: '2025'
doi: 10.3389/fcell.2025.1584630
journal_title: Frontiers in Cell and Developmental Biology
journal_nlm_ta: Front Cell Dev Biol
publisher_name: Frontiers Media SA
keywords: multidrug resistance | glucose metabolism | cancer metabolism | glycolysis
  | cancer therapy
automl_pathway: 0.9659797
figid_alias: PMC12222209__F1
figtype: Figure
redirect_from: /figures/PMC12222209__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12222209__fcell-13-1584630-g001.html
  '@type': Dataset
  description: The main mechanism for cancer undergoes MDR. The PI3K/Akt signaling
    pathway enhances the drug efflux capacity of ABC transporters by facilitating
    energy supply through aerobic glycolysis. Hypoxia-inducible factor 1-alpha (HIF-1α)
    activates the transcription of various genes, such as vascular endothelial growth
    factor (VEGF), glucose transporters, and glycolytic enzymes, thereby modulating
    glucose metabolism to support the Warburg effect and regulating the expression
    of ABC transport proteins. Additionally, c-Myc influences glucose metabolism and
    augments the expression and activity of ABCG2. These signaling pathways reprogram
    glucose metabolism and impact the expression of ABCs transporter proteins (P-gp,
    MRP1, ABCG2, etc.), resulting in cancer MDR. MDR, multidrug resistance; HIF-1α,
    hypoxia-inducible factor 1-alpha; VEGF, vascular endothelial growth factor; ABCG2,
    ATP-binding cassette transporter G2; P-gp, P-glycoprotein; MRP1, multidrug resistance
    related protein 1
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - HIF1A
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - ABCB6
  - CD9
  - MDM4
  - ABCC1
  - MSH3
  - PGP
  - ABCB1
  - PGPEP1
  - ABCG2
  - Glucose
  - MDR
---
